Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-028979
Filing Date
2021-02-04
Accepted
2021-02-04 17:12:01
Documents
8
Period of Report
2021-02-04

Document Format Files

Seq Description Document Type Size
1 6-K d117930d6k.htm 6-K 16083
2 EX-99.1 d117930dex991.htm EX-99.1 210024
3 EX-99.2 d117930dex992.htm EX-99.2 93126
4 EX-99.3 d117930dex993.htm EX-99.3 5254
5 EX-99.4 d117930dex994.htm EX-99.4 10837
6 EX-99.5 d117930dex995.htm EX-99.5 11056
7 GRAPHIC g117930g0203042611028.jpg GRAPHIC 55506
8 GRAPHIC g117930g0204101200082.jpg GRAPHIC 3023
  Complete submission text file 0001193125-21-028979.txt   427917
Mailing Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6
Business Address 880 - 580 HORNBY STREET VANCOUVER A1 V6C3B6 6048060626
ImmunoPrecise Antibodies Ltd. (Filer) CIK: 0001715925 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0430
Type: 6-K | Act: 34 | File No.: 001-39530 | Film No.: 21592165
SIC: 2834 Pharmaceutical Preparations